
Aditi Dutt
Examiner (ID: 17233, Phone: (571)272-9037 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1649, 1675 |
| Total Applications | 617 |
| Issued Applications | 220 |
| Pending Applications | 76 |
| Abandoned Applications | 327 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4994230
[patent_doc_number] => 20070009575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Novel use of antisecretory factor'
[patent_app_type] => utility
[patent_app_number] => 10/573601
[patent_app_country] => US
[patent_app_date] => 2004-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11431
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20070009575.pdf
[firstpage_image] =>[orig_patent_app_number] => 10573601
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/573601 | Novel use of antisecretory factor | Sep 23, 2004 | Abandoned |
Array
(
[id] => 7252095
[patent_doc_number] => 20050142533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Compositions and methods for promoting nerve regeneration'
[patent_app_type] => utility
[patent_app_number] => 10/943506
[patent_app_country] => US
[patent_app_date] => 2004-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10481
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142533.pdf
[firstpage_image] =>[orig_patent_app_number] => 10943506
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/943506 | Methods for identifying an analog that promotes nerve regeneration | Sep 16, 2004 | Issued |
Array
(
[id] => 5733459
[patent_doc_number] => 20060258576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Gdnf-related neuropeptides'
[patent_app_type] => utility
[patent_app_number] => 10/570460
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11298
[patent_no_of_claims] => 94
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258576.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570460
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570460 | Gdnf-related neuropeptides | Sep 2, 2004 | Abandoned |
Array
(
[id] => 7089988
[patent_doc_number] => 20050010042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => '26 human secreted proteins'
[patent_app_type] => utility
[patent_app_number] => 10/919272
[patent_app_country] => US
[patent_app_date] => 2004-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 138027
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20050010042.pdf
[firstpage_image] =>[orig_patent_app_number] => 10919272
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/919272 | 26 human secreted proteins | Aug 16, 2004 | Abandoned |
Array
(
[id] => 5112432
[patent_doc_number] => 20070196347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Methods for preventing neurological events'
[patent_app_type] => utility
[patent_app_number] => 10/567737
[patent_app_country] => US
[patent_app_date] => 2004-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11681
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20070196347.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567737
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567737 | Methods for preventing neurological events | Aug 11, 2004 | Abandoned |
Array
(
[id] => 5045603
[patent_doc_number] => 20070264276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Vaccine for the prevention and treatment of Alzheimer\'s and amyloid related diseases'
[patent_app_type] => utility
[patent_app_number] => 10/895646
[patent_app_country] => US
[patent_app_date] => 2004-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16053
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264276.pdf
[firstpage_image] =>[orig_patent_app_number] => 10895646
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/895646 | Vaccine for the prevention and treatment of Alzheimer's and amyloid related diseases | Jul 20, 2004 | Abandoned |
Array
(
[id] => 5655791
[patent_doc_number] => 20060141526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Genetic marker for coronary artery disease'
[patent_app_type] => utility
[patent_app_number] => 10/565487
[patent_app_country] => US
[patent_app_date] => 2004-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13730
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20060141526.pdf
[firstpage_image] =>[orig_patent_app_number] => 10565487
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/565487 | Genetic marker for coronary artery disease | Jul 20, 2004 | Abandoned |
Array
(
[id] => 415111
[patent_doc_number] => 07279308
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-09
[patent_title] => 'Polynucleotides encoding polypeptides having aminopeptidase activity'
[patent_app_type] => utility
[patent_app_number] => 10/883238
[patent_app_country] => US
[patent_app_date] => 2004-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 25284
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/279/07279308.pdf
[firstpage_image] =>[orig_patent_app_number] => 10883238
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/883238 | Polynucleotides encoding polypeptides having aminopeptidase activity | Jun 29, 2004 | Issued |
Array
(
[id] => 5242850
[patent_doc_number] => 20070021345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases'
[patent_app_type] => utility
[patent_app_number] => 10/562852
[patent_app_country] => US
[patent_app_date] => 2004-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 31698
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021345.pdf
[firstpage_image] =>[orig_patent_app_number] => 10562852
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/562852 | Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases | Jun 28, 2004 | Abandoned |
Array
(
[id] => 9112887
[patent_doc_number] => 08569056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-29
[patent_title] => 'Method for producing retinal neurocyte from neural stem cell derived from iris tissue'
[patent_app_type] => utility
[patent_app_number] => 10/559784
[patent_app_country] => US
[patent_app_date] => 2004-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 12628
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10559784
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559784 | Method for producing retinal neurocyte from neural stem cell derived from iris tissue | Jun 10, 2004 | Issued |
Array
(
[id] => 228705
[patent_doc_number] => 07601518
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-13
[patent_title] => 'Secretion of neublastin'
[patent_app_type] => utility
[patent_app_number] => 10/864891
[patent_app_country] => US
[patent_app_date] => 2004-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 18157
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/601/07601518.pdf
[firstpage_image] =>[orig_patent_app_number] => 10864891
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/864891 | Secretion of neublastin | Jun 9, 2004 | Issued |
Array
(
[id] => 9626337
[patent_doc_number] => 08796014
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-05
[patent_title] => 'Method for producing tissue cells from pluripotent stem cells derived from iris pigment epithelial cells of animal and tissue cell obtained by method'
[patent_app_type] => utility
[patent_app_number] => 10/559783
[patent_app_country] => US
[patent_app_date] => 2004-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 6893
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10559783
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559783 | Method for producing tissue cells from pluripotent stem cells derived from iris pigment epithelial cells of animal and tissue cell obtained by method | Jun 9, 2004 | Issued |
Array
(
[id] => 6991402
[patent_doc_number] => 20050090439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Vaccine for the prevention and treatment of Alzheimer\'s and amyloid related diseases'
[patent_app_type] => utility
[patent_app_number] => 10/825958
[patent_app_country] => US
[patent_app_date] => 2004-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5483
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090439.pdf
[firstpage_image] =>[orig_patent_app_number] => 10825958
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/825958 | Vaccine for the Prevention and Treatment of Alzheimer's and Amyloid Related Diseases | Apr 15, 2004 | Abandoned |
Array
(
[id] => 7329908
[patent_doc_number] => 20040254152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Prevention of deficits in neurogenesis with anti-inflammatory agents'
[patent_app_type] => new
[patent_app_number] => 10/826472
[patent_app_country] => US
[patent_app_date] => 2004-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17256
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254152.pdf
[firstpage_image] =>[orig_patent_app_number] => 10826472
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/826472 | Prevention of deficits in neurogenesis with anti-inflammatory agents | Apr 15, 2004 | Abandoned |
Array
(
[id] => 6991402
[patent_doc_number] => 20050090439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Vaccine for the prevention and treatment of Alzheimer\'s and amyloid related diseases'
[patent_app_type] => utility
[patent_app_number] => 10/825958
[patent_app_country] => US
[patent_app_date] => 2004-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5483
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090439.pdf
[firstpage_image] =>[orig_patent_app_number] => 10825958
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/825958 | Vaccine for the prevention and treatment of Alzheimer's and amyloid related diseases | Apr 15, 2004 | Abandoned |
Array
(
[id] => 5666578
[patent_doc_number] => 20060171928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Monocyte-origin multipotent cell momc'
[patent_app_type] => utility
[patent_app_number] => 10/549707
[patent_app_country] => US
[patent_app_date] => 2004-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11886
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20060171928.pdf
[firstpage_image] =>[orig_patent_app_number] => 10549707
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/549707 | Monocyte-origin multipotent cell MOMC | Mar 17, 2004 | Issued |
Array
(
[id] => 4921949
[patent_doc_number] => 20080070264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Intracellular Signaling-Induced Ret-Independent Gdnf Receptor-Effected Morphological Changes'
[patent_app_type] => utility
[patent_app_number] => 10/548147
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15194
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20080070264.pdf
[firstpage_image] =>[orig_patent_app_number] => 10548147
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/548147 | Intracellular Signaling-Induced Ret-Independent Gdnf Receptor-Effected Morphological Changes | Mar 4, 2004 | Abandoned |
Array
(
[id] => 7677168
[patent_doc_number] => 20040152658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Immediate early genes and methods of use therefor'
[patent_app_type] => new
[patent_app_number] => 10/792481
[patent_app_country] => US
[patent_app_date] => 2004-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24625
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152658.pdf
[firstpage_image] =>[orig_patent_app_number] => 10792481
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/792481 | Immediate early genes and methods of use therefor | Mar 1, 2004 | Abandoned |
Array
(
[id] => 7276282
[patent_doc_number] => 20040235733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Methods and reagents for reducing polyglutamine toxicity'
[patent_app_type] => new
[patent_app_number] => 10/789518
[patent_app_country] => US
[patent_app_date] => 2004-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13679
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 36
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235733.pdf
[firstpage_image] =>[orig_patent_app_number] => 10789518
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/789518 | Methods and reagents for reducing polyglutamine toxicity | Feb 26, 2004 | Abandoned |
Array
(
[id] => 7313040
[patent_doc_number] => 20040143859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Novel proteins and methods for producing the proteins'
[patent_app_type] => new
[patent_app_number] => 10/785114
[patent_app_country] => US
[patent_app_date] => 2004-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21176
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20040143859.pdf
[firstpage_image] =>[orig_patent_app_number] => 10785114
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/785114 | Methods for using the osteoclastogenesis inhibitory factor (OCIF) protein | Feb 24, 2004 | Issued |